Patents/Assignees

Vertex Pharmaceuticals Incorporated

103 patents in portfolio

US12612416utility2026
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
0 cites
US12612379utility2026
Inhibitors of APOL1 and Methods of Using Same
0 cites
US12577233utility2026
Solid Forms of APOL1 Inhibitor and Methods of Using Same
0 cites
US12552810utility2026
Crystalline Forms of CFTR Modulators
0 cites
US12544545utility2026
Macroencapsulation Devices
0 cites
US12508231utility2025
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
0 cites
US12503439utility2025
Heteroaryl Compounds for the Treatment of Pain
0 cites
US12502376utility2025
Pyrano[4,3-b]indole Derivatives as Alpha-1-antitrypsin Modulators for Treating Alpha-1-antitrypsin Deficiency (AATD)
0 cites
US12497614utility2025
Compositions and Methods for Editing Beta-globin for Treatment of Hemaglobinopathies
0 cites
US12492388utility2025
Materials and Methods for Treatment of Hemoglobinopathies
0 cites
US12458635utility2025
Pharmaceutical Composition and Administrations Thereof
0 cites
US12440481utility2025
Esters and Carbamates as Modulators of Sodium Channels
0 cites
US12441703utility2025
Carboxamides as Modulators of Sodium Channels
0 cites
US12442020utility2025
Materials and Methods for Treatment of Pain Related Disorders
0 cites
US12421251utility2025
Cystic Fibrosis Transmembrane Conductance Regulator Modulating Agents
0 cites
US12421249utility2025
Inhibitors of APOL1 and Methods of Using Same
0 cites
US12415798utility2025
Processes for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
0 cites
US12384790utility2025
Pteridinone Compounds and Uses Thereof
0 cites
US12384762utility2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator
0 cites
US12385013utility2025
Differentiation of Pancreatic Endocrine Cells
0 cites

Page 1 of 6Next →